Targeting conjugates with therapeutic agents and oligonucleotides and uses thereof
AssigneeAllygen Group
InventorsJun XIANG, Wenlong GAO
Life of this patent
Estimating the term…
Abstract
Provided are targeting conjugates comprising a targeting moiety, a therapeutic agent, and an oligonucleotide, wherein the oligonucleotide is attached to the targeting moiety via a targeting moiety binding fragment (TBF), wherein the therapeutic agent and/or the oligonucleotide can be released from the targeting conjugate via cleavage. Also provided are pharmaceutical compositions and methods of treatment using the targeting conjugates.
Claims18
1-74. (canceled)
A targeting conjugate comprising a targeting moiety, a therapeutic agent, and an oligonucleotide, wherein the therapeutic agent and/or the oligonucleotide can be released from the targeting conjugate via cleavage.
A targeting conjugate comprising a targeting moiety conjugated to a therapeutic agent or an oligonucleotide via a targeting moiety binding fragment (TBF), wherein the TBF comprises an amino acid sequence selected from any of SEQ ID NOs:
- 75-79 and 152.
A targeting conjugate comprising a targeting moiety conjugated to a therapeutic agent, wherein the therapeutic agent comprises a structure selected from the group consisting of Formulae (1)-(7).
Dependencies are inferred from the claim text.